Oct 30, 2013 | Inside, School
Ten faculty members were named endowed professors at the 2013 Convocation Ceremony on Monday, September 30, an event that marks the beginning of the academic year for the Icahn School of Medicine at Mount Sinai. The honorees, renowned in their respective fields—including allergy and immunology, cancer research, neuroscience, nephrology, otolaryngology, translational genetics, and transplant immunology—comprised the largest group named at one time at Mount Sinai.
(more…)
Oct 30, 2013 | Inside, School
One-hundred-forty first-year students from the Icahn School of Medicine at Mount Sinai symbolically marked the start of their medical education by receiving white coats and stethoscopes, and reciting a student oath at the 16th annual White Coat Ceremony, held recently in Stern Auditorium.
(more…)
Oct 8, 2013 | Inside, School, Your Health
The Boards of Trustees of The Mount Sinai Medical Center and Continuum Health Partners announced on Monday, September 30, the establishment of the Mount Sinai Health System. This new health system includes Icahn School of Medicine at Mount Sinai, seven major member hospital campuses in New York City, an extensive network of approximately 45 ambulatory care locations, 12 free-standing ambulatory surgery centers, and more than 40 clinical and academic relationships with local health care organizations—all throughout the greater metropolitan region.
(more…)
Oct 8, 2013 | Inside, School, Your Health
The Icahn School of Medicine at Mount Sinai, one of the nation’s leading medical schools, along with its Graduate School of Biomedical Sciences, will serve to integrate all clinical and research missions for the seven member hospital campuses and vast network of ambulatory facilities in the new Mount Sinai Health System.
(more…)
Sep 3, 2013 | Research, School, Your Health
Today’s standard therapies for cancer exist because people have participated in clinical trials – yet choosing to participate in a cancer clinical trial is an important personal decision that can be intimidating for many patients. In order to better help patients understand cancer clinical trials, the reasons to participate in them, and clinical research at Mount Sinai, The Tisch Cancer Institute has released a new video, “Clinical Trials at Mount Sinai: Moving the Field Forward.”
(more…)
Updated on Jun 30, 2022 | Neuroscience, Research, School
Multiple Sclerosis is an inflammatory demyelinating disorder of the Central Nervous System of debated etiology. While there is general consensus regarding the role of an active immune system in myelin destruction, the questions related to the initial events triggering immune system involvement remain unanswered and the identity of disease course modifiers is only partially understood. Epidemiological studies have suggested the possibility that disease onset and course are the result of an interaction between genetic susceptibility and environmental factors, though much remains to be learned about the identity of the environmental factors and whether they can be modified. Among the proposed variables affecting MS are geographic location, smoking, vitamin D levels and the much debated diet and infections.
(more…)
Ten faculty members were named endowed professors at the 2013 Convocation Ceremony on Monday, September 30, an event that marks the beginning of the academic year for the Icahn School of Medicine at Mount Sinai. The honorees, renowned in their respective fields—including allergy and immunology, cancer research, neuroscience, nephrology, otolaryngology, translational genetics, and transplant immunology—comprised the largest group named at one time at Mount Sinai.
